在中间膜干细胞中持续的安菲瑞古林表达驱动着渐进性纤维化
Rui Zhao1, Zheng Wang2, Guowu Wang1
1Pulmongene (Beijing) Ltd., Beijing 102206, China.
Cell stem cell
|August 3, 2024
概括
异形性肺纤维化 (IPF) 涉及到持久的中间膜干细胞. 用抗体向安菲瑞古林 (AREG) 显示出阻断肺纤维化进展和治疗这种致命疾病的希望.
科学领域:
- 肺部病理学 肺部病理学
- 干细胞生物学 干细胞生物学
- 纤维性疾病 纤维性疾病
背景情况:
- 异形性肺纤维化 (IPF) 是一种渐进的,致命的肺病.
- 中间膜干细胞在IPF肺部持续存在,与疾病进展相关.
研究的目的:
- 调查安菲瑞古林 (AREG) 在IPF病变发生中的作用.
- 评估在IPF中准AREG的治疗潜力.
主要方法:
- 在小鼠和人类IPF肺组织中检查了AREG表达.
- 评估了IPF患者血清AREG水平和肺功能之间的相关性.
- 研究了AREG在纤维细胞中激活EGFR的机制.
- 在肺纤维化小鼠模型中测试了抗AREG抗体的疗效.
主要成果:
- 在IPF中,AREG表达在中间膜干细胞中显著升高.
- 高血清AREG水平与IPF患者的严重肺功能下降相关.
- 在纤维细胞中,AREG会激活EGFR,从而导致肺纤维化.
- 在小鼠中,抗AREG抗体治疗阻断了肺纤维化开始和进展.
结论:
- 在IPF中驱动肺纤维化方面,AREG起着至关重要的作用.
- 用中和抗体向AREG为IPF提供了一个有前途的治疗策略.
相关概念视频
Alveoli and Alveolar Ducts
The respiratory zone of the human body, which stands in contrast to the conducting zone, comprises the structures that actively participate in the exchange of gases. The initiation of this zone is marked by the terminal bronchioles converging into respiratory bronchioles, the tiniest bronchiole classification. The respiratory bronchioles give way to the alveolar ducts that opens into a congregation of alveoli. Actively involved in gas exchange, alveoli resemble tiny sacs similar to clusters of...
Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...


